S.22 (Act 61)
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration
Sponsors:
Sen. Virginia Lyons
,
Sen. Richard McCormack
Last Recorded Action: 3/10/2021 - 3rd reading ordered
Staff & Other Information
Regular Session 2021-2022
- Staff
- Jennifer Carbee